Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia
Top Cited Papers
- 1 February 2001
- journal article
- guideline
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 86 (2) , 283-287
- https://doi.org/10.1093/bja/86.2.283
Abstract
Malignant hyperthermia (MH) is a potentially fatal pharmacogenetic disease triggered by several anaesthetic agents. The in vitro muscle contracture test (IVCT) is the standard test to establish an individual’s risk of susceptibility to MH. Clinical practitioners and geneticists of the European MH Group have agreed on the present guidelines for the detection of MH susceptibility using molecular genetic techniques and/or IVCT to predict the risk of MH. Br J Anaesth 2001; 86: 283–7Keywords
This publication has 22 references indexed in Scilit:
- Identification of Novel Mutations in the Ryanodine-Receptor Gene (RYR1) in Malignant Hyperthermia: Genotype-Phenotype CorrelationAmerican Journal of Human Genetics, 1998
- Detection of a novel mutation at amino acid position 614 in the ryanodine receptor in malignant hyperthermiaBritish Journal of Anaesthesia, 1997
- In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: Results of testing patients surviving fulminant MH and unrelated low‐risk subjectsActa Anaesthesiologica Scandinavica, 1997
- Detection of a novel mutation in the ryanodine receptor gene in an Irish malignant hyperthermia pedigree: correlation of the IVCT response with the affected and unaffected haplotypes.Journal of Medical Genetics, 1997
- Identification of Heterozygous and Homozygous Individuals with the Novel RYR1 Mutation Cys35Arg in a Large KindredAnesthesiology, 1997
- Mutation Screening of the RYR1 Gene in Malignant Hyperthermia: Detection of a Novel Tyr to Ser Mutation in a Pedigree with Associated Central CoresGenomics, 1994
- Detection of a novel common mutation in the ryanodine receptor gene in malignant hyperthermia: implications for diagnosis and heterogeneity studiesHuman Molecular Genetics, 1994
- Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermiaNature Genetics, 1993
- Polymorphisms and deduced amino acid substitutions in the coding sequence of the ryanodine receptor (RYR1) gene in individuals with malignant hyperthermiaGenomics, 1992
- A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermiaGenomics, 1991